PDCD1 and hepatocellular carcinoma: Finally, despite the poor number of clinical trials regarding the relationship between A. muciniphila and HCC, ongoing phase I studies are exploring the safety and feasibility of A. muciniphila probiotics in combination with anti-PD-1 monoclonal antibodies in patients with advanced colorectal cancer (NCT06865521).